Imagerie cérébrale dans les syndromes parkinsoniens

Vaillancourt, 2009, High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease, Neurology, 72, 1378, 10.1212/01.wnl.0000340982.01727.6e Noh, 2015, Nigrosome 1 Detection at 3T MRI for the diagnosis of early-stage idiopathic Parkinson disease: assessment of diagnostic accuracy and agreement on imaging asymmetry and clinical laterality, AJNR Am J Neuroradiol, 36, 2010, 10.3174/ajnr.A4412 Kim, 2016, Loss of substantia nigra hyperintensity on 7 Tesla MRI of Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy, Parkinsonism Relat Disord, 26, 47, 10.1016/j.parkreldis.2016.01.023 Martin, 2008, Midbrain iron content in early Parkinson's disease. A potential biomarker of disease status, Neurology, 70, 1411, 10.1212/01.wnl.0000286384.31050.b5 Lehéricy, 2012, Magnetic resonance imaging of the substantia nigra in Parkinson's disease, Mov Disord, 27, 822, 10.1002/mds.25015 Scherfler, 2007, Role of DAT-SPECT in the diagnostic work up of parkinsonism, Mov Disord, 22, 1229, 10.1002/mds.21505 Kupsch, 2012, J Neurol Neurosurg Psychiatry, 83, 620, 10.1136/jnnp-2011-301695 Tang, 2010, Abnormal metabolic brain networks in Parkinson's disease from blackboard to bedside, Prog Brain Res, 184, 161 Deverdun, 2014, Diffusion tensor imaging differentiates vascular parkinsonism from parkinsonian syndromes of degenerative origin in elderly subjects, Eur J Radiol, 83, 2074, 10.1016/j.ejrad.2014.07.012 Sung, 2016, Drug-induced parkinsonism versus idiopathic Parkinson disease: utility of nigrosome 1 with 3-T imaging, Radiology, 279, 849, 10.1148/radiol.2015151466 Sugiyama, 2015, Putaminal hypointensity on T2*-weighted MR imaging is the most practically useful sign in diagnosing multiple system atrophy: a preliminary study, J Neurol Sci, 349, 174, 10.1016/j.jns.2015.01.013 Savoiardo, 1997, MRI in sporadic olivopontocerebellar atrophy and striatonigral degeneration, Neurology, 48, 790, 10.1212/WNL.48.3.790 Oba, 2005, New and reliable MRI diagnosis for progressive supranuclear palsy, Neurology, 64, 2050, 10.1212/01.WNL.0000165960.04422.D0 Quattrone, 2008, MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy, Radiology, 246, 214, 10.1148/radiol.2453061703 Morelli, 2014, Effect of aging on magnetic resonance measures differentiating progressive supranuclear palsy from Parkinson's disease, Mov Disord, 29, 488, 10.1002/mds.25821 Fatterpekar, 2015, Cerebral peduncle angle: an objective criterion for assessing progressive supranuclear palsy Richardson syndrome, Am J Roentgenol, 205, 386, 10.2214/AJR.14.12724 Boxer, 2006, Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy, Arch Neurol, 63, 81, 10.1001/archneur.63.1.81 Scherfler, 2016, Diagnostic potential of automated subcortical volume segmentation in atypical parkinsonism, Neurology, 86, 1242, 10.1212/WNL.0000000000002518 Baudrexel, 2014, The value of putaminal diffusion imaging versus 18-fluorodeoxyglucose positron emission tomography for the differential diagnosis of the Parkinson variant of multiple system atrophy, Mov Disord, 29, 380, 10.1002/mds.25749 Tsukamoto, 2012, Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson's disease: evaluation by 3.0-T MR imaging, Neuroradiology, 54, 947, 10.1007/s00234-012-1009-9 Nicoletti, 2013, Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease, Radiology, 267, 843, 10.1148/radiol.12120364 Ohtsuka, 2014, Differentiation of early-stage parkinsonisms using neuromelanin-sensitive magnetic resonance imaging, Parkinsonism Relat Disord, 20, 755, 10.1016/j.parkreldis.2014.04.005 Reimão, 2015, Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease, Mov Disord, 30, 953, 10.1002/mds.26182 Benaderette, 2006, Psychogenic parkinsonism: a combination of clinical, electrophysiological and [(123)I]-FP-CIT SPECT scan explorations improves diagnostic accuracy, Mov Disord, 21, 310, 10.1002/mds.20720 Gerschlager, 2002, [123I]beta-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease, Mov Disord, 17, 518, 10.1002/mds.10092 Südmeyer, 2011, Diagnostic accuracy of combined FP-CIT, IBZM and MIBG scintigraphy in the differential diagnosis of degenerative parkinsonism: a multidimensional statistical approach, J Nucl Med, 52, 733, 10.2967/jnumed.110.086959 Plotkin, 2005, Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients, J Neural Transm, 112, 677, 10.1007/s00702-004-0208-x Seppi, 2004, Comparison of diffusion-weighted imaging and [123I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease, Mov Disord, 19, 1438, 10.1002/mds.20229 Hellwig, 2012, [18F]FDG-PET is superior to [123I]IBZM-SPECT for the differential diagnosis of parkinsonism, Neurology, 79, 1314, 10.1212/WNL.0b013e31826c1b0a Yoon, 2015, The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson's disease: correlation with 18F-flurodeoxyglucose positron-emission tomography, Neurosci Lett, 584, 296, 10.1016/j.neulet.2014.10.046